BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Seattle - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Seattle
X-ORIGINAL-URL:https://scienceinseattle.com
X-WR-CALDESC:Events for Science in Seattle
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220416T163000
DTEND;TZID=America/Vancouver:20220416T180000
DTSTAMP:20260404T054718
CREATED:20220411T164440Z
LAST-MODIFIED:20220411T164440Z
UID:26837-1650126600-1650132000@scienceinseattle.com
SUMMARY:Sk8 to Elimin8 Cancer
DESCRIPTION:Cancer knows no bounds of gender\, age\, or race – it impacts everyone. In 2022 it’s estimated that a little more than 1.9 million new cancer cases will be diagnosed in the U.S. alone\, and 609\,360 people will die. That’s more than 1 person every minute dying because of this terrible disease. The Kingsgate Figure Skating Club is proud to partner with the Scott Hamilton CARES Foundation (CARES) to present Sk8 to Elimin8 Cancer™ Kirkland\, Washington! Proceeds from this event will support CARES’ national cancer research grants and their healthcare partners here in Washington\, Seattle Children’s. $25 General Admission; free to Registered Sk8 to Elimin8 Cancer™ participants. Rental skates are available for free.
URL:https://scienceinseattle.com/event/sk8-to-elimin8-cancer-3/
LOCATION:Sno-King Ice Arenas\, 14326 124th Ave NE\, Kirkland\, WA\, 98034\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220419T140000
DTEND;TZID=America/Vancouver:20220419T150000
DTSTAMP:20260404T054718
CREATED:20220411T165303Z
LAST-MODIFIED:20220411T165303Z
UID:17414-1650376800-1650380400@scienceinseattle.com
SUMMARY:Exploring Family Connections Using DNA
DESCRIPTION:Workshop Announcement \nExploring Family Connections Using DNA \nDate: Tues Apr 19\, 2022 Time: 2:00 pm Pacific / 5:00 pm Eastern \nIn this workshop\, you will learn how to use DNA resources to find out how closely you are related to other people who share your variant and to search for additional relatives who might have your variant. It is not necessary for you to have already done genetic testing to find out your genetic heritage\, but those who have already done this testing may benefit the most. \nRegistration: Click HERE to register in advance for this meeting. (After registering\, you will receive a confirmation email containing information about joining the meeting.)
URL:https://scienceinseattle.com/event/exploring-family-connections-using-dna/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220419T140000
DTEND;TZID=America/Vancouver:20220419T150000
DTSTAMP:20260404T054718
CREATED:20220411T165303Z
LAST-MODIFIED:20220411T165303Z
UID:25874-1650376800-1650380400@scienceinseattle.com
SUMMARY:Exploring Family Connections Using DNA
DESCRIPTION:Workshop Announcement \nExploring Family Connections Using DNA \nDate: Tues Apr 19\, 2022 Time: 2:00 pm Pacific / 5:00 pm Eastern \nIn this workshop\, you will learn how to use DNA resources to find out how closely you are related to other people who share your variant and to search for additional relatives who might have your variant. It is not necessary for you to have already done genetic testing to find out your genetic heritage\, but those who have already done this testing may benefit the most. \nRegistration: Click HERE to register in advance for this meeting. (After registering\, you will receive a confirmation email containing information about joining the meeting.)
URL:https://scienceinseattle.com/event/exploring-family-connections-using-dna-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220419T140000
DTEND;TZID=America/Vancouver:20220419T150000
DTSTAMP:20260404T054718
CREATED:20220411T165303Z
LAST-MODIFIED:20220411T165303Z
UID:26839-1650376800-1650380400@scienceinseattle.com
SUMMARY:Exploring Family Connections Using DNA
DESCRIPTION:Workshop Announcement \nExploring Family Connections Using DNA \nDate: Tues Apr 19\, 2022 Time: 2:00 pm Pacific / 5:00 pm Eastern \nIn this workshop\, you will learn how to use DNA resources to find out how closely you are related to other people who share your variant and to search for additional relatives who might have your variant. It is not necessary for you to have already done genetic testing to find out your genetic heritage\, but those who have already done this testing may benefit the most. \nRegistration: Click HERE to register in advance for this meeting. (After registering\, you will receive a confirmation email containing information about joining the meeting.)
URL:https://scienceinseattle.com/event/exploring-family-connections-using-dna-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220420
DTEND;VALUE=DATE:20220422
DTSTAMP:20260404T054718
CREATED:20220214T182621Z
LAST-MODIFIED:20220214T182645Z
UID:16663-1650412800-1650585599@scienceinseattle.com
SUMMARY:Life Science Innovation Northwest 2022
DESCRIPTION:Life Science Innovation Northwest (LSINW) is the Pacific Northwest’s largest annual life science conference. This one-and-a-half day event will bring together investors\, public and private life science organizations\, research institutions\, scientists\, entrepreneurs\, and the global health community to discuss and feature some of the most compelling life science breakthroughs of our time. \n2022 Keynote Speaker: Dr. Patrick Yang \nDr. Patrick Yang is a world-leading biomanufacturing expert and co-founder of Resilience\, a first-in-kind manufacturing\, and services operation providing novel ways to manufacture cell and gene therapies\, among others\, and supported with over $800M in financing. Previously\, Pat was the Executive Vice President and special advisor for Juno Therapeutics and Executive Vice President and Global Head of Technical Operations at Roche\, where he was responsible for the company’s pharmaceutical process development\, engineering\, quality\, technical regulatory\, supply chain\, and all manufacturing plants. \nRegistration Fees\n\n\n\n2022 LSINW Registration Rates\nEarly Bird Deadline\n04/08/2022\nAfter Early Bird and Onsite\n\n\nDisplaced Life Science Industry Employee\n$400\n$550\n\n\nInternational Delegate\n$500\n$550\n\n\nInvestor\n$100\n$200\n\n\nLSW Member: Academic\, Nonprofit or Government\n$400\n$550\n\n\nLSW Member: Associate Service Provider\n$1050\n$1300\n\n\nLSW Member: Core Company\n$800\n$1050\n\n\nLSW Member: Emerging Core Company*\n$400\n$525\n\n\nNon-Member: Core Company\n$1100\n$1350\n\n\nNon-Member: Academic or Nonprofit\n$700\n$850\n\n\nNon-Member: Service Provider\n$1350\n$1600\n\n\nQualified Media\n$0\n$0\n\n\nReception Only\n\n\n\n\nIndustry Reception Only – Members\n$250\n$250\n\n\nIndustry Reception Only – Non-Members\n$350\n$350\n\n\nVirtual\n\n\n\n\nGroup Pass – Company Presentations\n$1000\n$1000\n\n\nIndividual Pass – Company Presentations\n$400\n$400
URL:https://scienceinseattle.com/event/life-science-innovation-northwest-2022/
LOCATION:Washington State Convention Center\, 705 Pike St\, Seattle\, 98101\, United States
ATTACH;FMTTYPE=image/png:https://scienceinseattle.com/wp-content/uploads/sites/4/2022/02/LSINW22_Keynote_Yang-v1-768x384-1.png
ORGANIZER;CN="Life Science Washington":MAILTO:kaitlyn@lifesciencewa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220420
DTEND;VALUE=DATE:20220422
DTSTAMP:20260404T054718
CREATED:20220214T182621Z
LAST-MODIFIED:20220214T182621Z
UID:25844-1650412800-1650585599@scienceinseattle.com
SUMMARY:Life Science Innovation Northwest 2022
DESCRIPTION:Life Science Innovation Northwest (LSINW) is the Pacific Northwest’s largest annual life science conference. This one-and-a-half day event will bring together investors\, public and private life science organizations\, research institutions\, scientists\, entrepreneurs\, and the global health community to discuss and feature some of the most compelling life science breakthroughs of our time. \n2022 Keynote Speaker: Dr. Patrick Yang \nDr. Patrick Yang is a world-leading biomanufacturing expert and co-founder of Resilience\, a first-in-kind manufacturing\, and services operation providing novel ways to manufacture cell and gene therapies\, among others\, and supported with over $800M in financing. Previously\, Pat was the Executive Vice President and special advisor for Juno Therapeutics and Executive Vice President and Global Head of Technical Operations at Roche\, where he was responsible for the company’s pharmaceutical process development\, engineering\, quality\, technical regulatory\, supply chain\, and all manufacturing plants. \nRegistration Fees\n\n\n\n2022 LSINW Registration Rates\nEarly Bird Deadline\n04/08/2022\nAfter Early Bird and Onsite\n\n\nDisplaced Life Science Industry Employee\n$400\n$550\n\n\nInternational Delegate\n$500\n$550\n\n\nInvestor\n$100\n$200\n\n\nLSW Member: Academic\, Nonprofit or Government\n$400\n$550\n\n\nLSW Member: Associate Service Provider\n$1050\n$1300\n\n\nLSW Member: Core Company\n$800\n$1050\n\n\nLSW Member: Emerging Core Company*\n$400\n$525\n\n\nNon-Member: Core Company\n$1100\n$1350\n\n\nNon-Member: Academic or Nonprofit\n$700\n$850\n\n\nNon-Member: Service Provider\n$1350\n$1600\n\n\nQualified Media\n$0\n$0\n\n\nReception Only\n\n\n\n\nIndustry Reception Only – Members\n$250\n$250\n\n\nIndustry Reception Only – Non-Members\n$350\n$350\n\n\nVirtual\n\n\n\n\nGroup Pass – Company Presentations\n$1000\n$1000\n\n\nIndividual Pass – Company Presentations\n$400\n$400
URL:https://scienceinseattle.com/event/life-science-innovation-northwest-2022-2/
LOCATION:Washington State Convention Center\, 705 Pike St\, Seattle\, 98101\, United States
ATTACH;FMTTYPE=image/png:https://scienceinseattle.com/wp-content/uploads/sites/4/2022/02/LSINW22_Keynote_Yang-v1-768x384-1.png
ORGANIZER;CN="Life Science Washington":MAILTO:kaitlyn@lifesciencewa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220420
DTEND;VALUE=DATE:20220422
DTSTAMP:20260404T054718
CREATED:20220214T182621Z
LAST-MODIFIED:20220214T182621Z
UID:26809-1650412800-1650585599@scienceinseattle.com
SUMMARY:Life Science Innovation Northwest 2022
DESCRIPTION:Life Science Innovation Northwest (LSINW) is the Pacific Northwest’s largest annual life science conference. This one-and-a-half day event will bring together investors\, public and private life science organizations\, research institutions\, scientists\, entrepreneurs\, and the global health community to discuss and feature some of the most compelling life science breakthroughs of our time. \n2022 Keynote Speaker: Dr. Patrick Yang \nDr. Patrick Yang is a world-leading biomanufacturing expert and co-founder of Resilience\, a first-in-kind manufacturing\, and services operation providing novel ways to manufacture cell and gene therapies\, among others\, and supported with over $800M in financing. Previously\, Pat was the Executive Vice President and special advisor for Juno Therapeutics and Executive Vice President and Global Head of Technical Operations at Roche\, where he was responsible for the company’s pharmaceutical process development\, engineering\, quality\, technical regulatory\, supply chain\, and all manufacturing plants. \nRegistration Fees\n\n\n\n2022 LSINW Registration Rates\nEarly Bird Deadline\n04/08/2022\nAfter Early Bird and Onsite\n\n\nDisplaced Life Science Industry Employee\n$400\n$550\n\n\nInternational Delegate\n$500\n$550\n\n\nInvestor\n$100\n$200\n\n\nLSW Member: Academic\, Nonprofit or Government\n$400\n$550\n\n\nLSW Member: Associate Service Provider\n$1050\n$1300\n\n\nLSW Member: Core Company\n$800\n$1050\n\n\nLSW Member: Emerging Core Company*\n$400\n$525\n\n\nNon-Member: Core Company\n$1100\n$1350\n\n\nNon-Member: Academic or Nonprofit\n$700\n$850\n\n\nNon-Member: Service Provider\n$1350\n$1600\n\n\nQualified Media\n$0\n$0\n\n\nReception Only\n\n\n\n\nIndustry Reception Only – Members\n$250\n$250\n\n\nIndustry Reception Only – Non-Members\n$350\n$350\n\n\nVirtual\n\n\n\n\nGroup Pass – Company Presentations\n$1000\n$1000\n\n\nIndividual Pass – Company Presentations\n$400\n$400
URL:https://scienceinseattle.com/event/life-science-innovation-northwest-2022-3/
LOCATION:Washington State Convention Center\, 705 Pike St\, Seattle\, 98101\, United States
ATTACH;FMTTYPE=image/png:https://scienceinseattle.com/wp-content/uploads/sites/4/2022/02/LSINW22_Keynote_Yang-v1-768x384-1.png
ORGANIZER;CN="Life Science Washington":MAILTO:kaitlyn@lifesciencewa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220425T080000
DTEND;TZID=America/Vancouver:20220425T090000
DTSTAMP:20260404T054718
CREATED:20220328T192638Z
LAST-MODIFIED:20220328T192638Z
UID:17225-1650873600-1650877200@scienceinseattle.com
SUMMARY:Global Oncology Lecture Series - Julie R. Gralow
DESCRIPTION:Julie R. Gralow\, MD\, FACP\, FASCO  \n\nExecutive Vice President and Chief Medical Officer\, American Society of Clinical Oncology\nAffiliate Professor (emeritus) Department of Global Health\, University of Washington\nAffiliate Professor (emeritus)\, Ellison Center for Russian\, East European\, and Central Asian Studies\, Henry M. Jackson School of International Studies\, University of Washington\n\nSeminar Title: “Cancer Care in Ukraine: Reflecting on 25 Years of Collaboration and the Impact of War on Cancer Patients and Physicians”
URL:https://scienceinseattle.com/event/global-oncology-lecture-series-julie-r-gralow/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220425T080000
DTEND;TZID=America/Vancouver:20220425T090000
DTSTAMP:20260404T054718
CREATED:20220328T192638Z
LAST-MODIFIED:20220328T192638Z
UID:25866-1650873600-1650877200@scienceinseattle.com
SUMMARY:Global Oncology Lecture Series - Julie R. Gralow
DESCRIPTION:Julie R. Gralow\, MD\, FACP\, FASCO  \n\nExecutive Vice President and Chief Medical Officer\, American Society of Clinical Oncology\nAffiliate Professor (emeritus) Department of Global Health\, University of Washington\nAffiliate Professor (emeritus)\, Ellison Center for Russian\, East European\, and Central Asian Studies\, Henry M. Jackson School of International Studies\, University of Washington\n\nSeminar Title: “Cancer Care in Ukraine: Reflecting on 25 Years of Collaboration and the Impact of War on Cancer Patients and Physicians”
URL:https://scienceinseattle.com/event/global-oncology-lecture-series-julie-r-gralow-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220425T080000
DTEND;TZID=America/Vancouver:20220425T090000
DTSTAMP:20260404T054718
CREATED:20220328T192638Z
LAST-MODIFIED:20220328T192638Z
UID:26831-1650873600-1650877200@scienceinseattle.com
SUMMARY:Global Oncology Lecture Series - Julie R. Gralow
DESCRIPTION:Julie R. Gralow\, MD\, FACP\, FASCO  \n\nExecutive Vice President and Chief Medical Officer\, American Society of Clinical Oncology\nAffiliate Professor (emeritus) Department of Global Health\, University of Washington\nAffiliate Professor (emeritus)\, Ellison Center for Russian\, East European\, and Central Asian Studies\, Henry M. Jackson School of International Studies\, University of Washington\n\nSeminar Title: “Cancer Care in Ukraine: Reflecting on 25 Years of Collaboration and the Impact of War on Cancer Patients and Physicians”
URL:https://scienceinseattle.com/event/global-oncology-lecture-series-julie-r-gralow-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220426T080000
DTEND;TZID=UTC:20220426T234500
DTSTAMP:20260404T054718
CREATED:20220228T191119Z
LAST-MODIFIED:20220228T191119Z
UID:16859-1650960000-1651016700@scienceinseattle.com
SUMMARY:World IP Day: Innovating For a Better Future
DESCRIPTION:Across the globe\, people are stepping up to innovation challenges\, using their energy and ingenuity\, their curiosity and creativity to steer a course towards a better future. This year\, the World Intellectual Property Day 2022’s theme focuses on Innovating for a Better Future. We explore how innovative\, energetic and creative minds are driving positive change.
URL:https://scienceinseattle.com/event/world-ip-day-innovating-for-a-better-future/
LOCATION:Online
ORGANIZER;CN="Life Science Washington":MAILTO:kaitlyn@lifesciencewa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220426T080000
DTEND;TZID=UTC:20220426T234500
DTSTAMP:20260404T054718
CREATED:20220228T191119Z
LAST-MODIFIED:20220228T191119Z
UID:25862-1650960000-1651016700@scienceinseattle.com
SUMMARY:World IP Day: Innovating For a Better Future
DESCRIPTION:Across the globe\, people are stepping up to innovation challenges\, using their energy and ingenuity\, their curiosity and creativity to steer a course towards a better future. This year\, the World Intellectual Property Day 2022’s theme focuses on Innovating for a Better Future. We explore how innovative\, energetic and creative minds are driving positive change.
URL:https://scienceinseattle.com/event/world-ip-day-innovating-for-a-better-future-2/
LOCATION:Online
ORGANIZER;CN="Life Science Washington":MAILTO:kaitlyn@lifesciencewa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220426T080000
DTEND;TZID=UTC:20220426T234500
DTSTAMP:20260404T054718
CREATED:20220228T191119Z
LAST-MODIFIED:20220228T191119Z
UID:26827-1650960000-1651016700@scienceinseattle.com
SUMMARY:World IP Day: Innovating For a Better Future
DESCRIPTION:Across the globe\, people are stepping up to innovation challenges\, using their energy and ingenuity\, their curiosity and creativity to steer a course towards a better future. This year\, the World Intellectual Property Day 2022’s theme focuses on Innovating for a Better Future. We explore how innovative\, energetic and creative minds are driving positive change.
URL:https://scienceinseattle.com/event/world-ip-day-innovating-for-a-better-future-3/
LOCATION:Online
ORGANIZER;CN="Life Science Washington":MAILTO:kaitlyn@lifesciencewa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220426T100000
DTEND;TZID=UTC:20220426T110000
DTSTAMP:20260404T054718
CREATED:20220411T165036Z
LAST-MODIFIED:20220411T165036Z
UID:17411-1650967200-1650970800@scienceinseattle.com
SUMMARY:The Virtual Science Lab: Does Organelle Shape Matter?
DESCRIPTION:Join Carlos C. Goller of North Carolina State University to learn how to use his open lesson plan\, “Does Organelle Shape Matter?” with your students. This lesson\, developed in collaboration with Kaitlyn Casimo and Graham Johnson at the Allen Institute\, uses open data resources from the Allen Institute for Cell Science to teach organelle morphology\, analysis of large high-throughput cell datasets\, and interpretation of cell image datasets. Kim Metzler of the Allen Institute for Cell Science presents a scientific introduction to the Allen Cell Explorer used in the lesson\, which includes images of the Allen Cell Collection of cell lines. \nThis lesson is intended for college instructors teaching intermediate to advanced courses in cell biology\, and may be adapted for students in advanced high school\, introductory college\, or graduate courses. A recording of the webinar will be available afterwards.
URL:https://scienceinseattle.com/event/the-virtual-science-lab-does-organelle-shape-matter/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220426T100000
DTEND;TZID=UTC:20220426T110000
DTSTAMP:20260404T054718
CREATED:20220411T165036Z
LAST-MODIFIED:20220411T165036Z
UID:25873-1650967200-1650970800@scienceinseattle.com
SUMMARY:The Virtual Science Lab: Does Organelle Shape Matter?
DESCRIPTION:Join Carlos C. Goller of North Carolina State University to learn how to use his open lesson plan\, “Does Organelle Shape Matter?” with your students. This lesson\, developed in collaboration with Kaitlyn Casimo and Graham Johnson at the Allen Institute\, uses open data resources from the Allen Institute for Cell Science to teach organelle morphology\, analysis of large high-throughput cell datasets\, and interpretation of cell image datasets. Kim Metzler of the Allen Institute for Cell Science presents a scientific introduction to the Allen Cell Explorer used in the lesson\, which includes images of the Allen Cell Collection of cell lines. \nThis lesson is intended for college instructors teaching intermediate to advanced courses in cell biology\, and may be adapted for students in advanced high school\, introductory college\, or graduate courses. A recording of the webinar will be available afterwards.
URL:https://scienceinseattle.com/event/the-virtual-science-lab-does-organelle-shape-matter-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220426T100000
DTEND;TZID=UTC:20220426T110000
DTSTAMP:20260404T054718
CREATED:20220411T165036Z
LAST-MODIFIED:20220411T165036Z
UID:26838-1650967200-1650970800@scienceinseattle.com
SUMMARY:The Virtual Science Lab: Does Organelle Shape Matter?
DESCRIPTION:Join Carlos C. Goller of North Carolina State University to learn how to use his open lesson plan\, “Does Organelle Shape Matter?” with your students. This lesson\, developed in collaboration with Kaitlyn Casimo and Graham Johnson at the Allen Institute\, uses open data resources from the Allen Institute for Cell Science to teach organelle morphology\, analysis of large high-throughput cell datasets\, and interpretation of cell image datasets. Kim Metzler of the Allen Institute for Cell Science presents a scientific introduction to the Allen Cell Explorer used in the lesson\, which includes images of the Allen Cell Collection of cell lines. \nThis lesson is intended for college instructors teaching intermediate to advanced courses in cell biology\, and may be adapted for students in advanced high school\, introductory college\, or graduate courses. A recording of the webinar will be available afterwards.
URL:https://scienceinseattle.com/event/the-virtual-science-lab-does-organelle-shape-matter-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220427T093000
DTEND;TZID=America/Vancouver:20220427T103000
DTSTAMP:20260404T054718
CREATED:20220328T192739Z
LAST-MODIFIED:20220328T192739Z
UID:17228-1651051800-1651055400@scienceinseattle.com
SUMMARY:Distinguished Seminar: Mackenzie Mathis
DESCRIPTION:Date:\nWednesday\, April 27\, 2022\nTime:\n9:30 AM – 10:30 AM\n\n\nRegister to join us for this virtual Distinguished Seminar Series with Mackenzie Mathis.
URL:https://scienceinseattle.com/event/distinguished-seminar-mackenzie-mathis/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220427T093000
DTEND;TZID=America/Vancouver:20220427T103000
DTSTAMP:20260404T054718
CREATED:20220328T192739Z
LAST-MODIFIED:20220328T192739Z
UID:25867-1651051800-1651055400@scienceinseattle.com
SUMMARY:Distinguished Seminar: Mackenzie Mathis
DESCRIPTION:Date:\nWednesday\, April 27\, 2022\nTime:\n9:30 AM – 10:30 AM\n\n\nRegister to join us for this virtual Distinguished Seminar Series with Mackenzie Mathis.
URL:https://scienceinseattle.com/event/distinguished-seminar-mackenzie-mathis-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220427T093000
DTEND;TZID=America/Vancouver:20220427T103000
DTSTAMP:20260404T054718
CREATED:20220328T192739Z
LAST-MODIFIED:20220328T192739Z
UID:26832-1651051800-1651055400@scienceinseattle.com
SUMMARY:Distinguished Seminar: Mackenzie Mathis
DESCRIPTION:Date:\nWednesday\, April 27\, 2022\nTime:\n9:30 AM – 10:30 AM\n\n\nRegister to join us for this virtual Distinguished Seminar Series with Mackenzie Mathis.
URL:https://scienceinseattle.com/event/distinguished-seminar-mackenzie-mathis-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220503T090000
DTEND;TZID=America/Vancouver:20220503T100000
DTSTAMP:20260404T054718
CREATED:20220502T180844Z
LAST-MODIFIED:20220502T180844Z
UID:17772-1651568400-1651572000@scienceinseattle.com
SUMMARY:May Variant Effect Seminar Series
DESCRIPTION:Antonio Mollica Cohn lab\, University of Toronto \nPresentation Date: May 03\, 2022 \n“Identifying novel pathogenic mechanisms in brain development disorders” \nAntonio is a PhD candidate in Ronald Cohn’s laboratory at the Hospital for Sick Children in Toronto. He is interested in the challenges of gene discovery for rare genetic diseases. His work focuses on defining a novel role for variants causing complex brain development disorders. \nSocial: N/A
URL:https://scienceinseattle.com/event/may-variant-effect-seminar-series/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220503T090000
DTEND;TZID=America/Vancouver:20220503T100000
DTSTAMP:20260404T054718
CREATED:20220502T180844Z
LAST-MODIFIED:20220502T180844Z
UID:25891-1651568400-1651572000@scienceinseattle.com
SUMMARY:May Variant Effect Seminar Series
DESCRIPTION:Antonio Mollica Cohn lab\, University of Toronto \nPresentation Date: May 03\, 2022 \n“Identifying novel pathogenic mechanisms in brain development disorders” \nAntonio is a PhD candidate in Ronald Cohn’s laboratory at the Hospital for Sick Children in Toronto. He is interested in the challenges of gene discovery for rare genetic diseases. His work focuses on defining a novel role for variants causing complex brain development disorders. \nSocial: N/A
URL:https://scienceinseattle.com/event/may-variant-effect-seminar-series-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220503T090000
DTEND;TZID=America/Vancouver:20220503T100000
DTSTAMP:20260404T054718
CREATED:20220502T180844Z
LAST-MODIFIED:20220502T180844Z
UID:26856-1651568400-1651572000@scienceinseattle.com
SUMMARY:May Variant Effect Seminar Series
DESCRIPTION:Antonio Mollica Cohn lab\, University of Toronto \nPresentation Date: May 03\, 2022 \n“Identifying novel pathogenic mechanisms in brain development disorders” \nAntonio is a PhD candidate in Ronald Cohn’s laboratory at the Hospital for Sick Children in Toronto. He is interested in the challenges of gene discovery for rare genetic diseases. His work focuses on defining a novel role for variants causing complex brain development disorders. \nSocial: N/A
URL:https://scienceinseattle.com/event/may-variant-effect-seminar-series-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220504T120000
DTEND;TZID=America/Vancouver:20220504T130000
DTSTAMP:20260404T054718
CREATED:20220411T165417Z
LAST-MODIFIED:20220411T165417Z
UID:17417-1651665600-1651669200@scienceinseattle.com
SUMMARY:Cellular Therapy Series Part I: How Engineered Cellular Therapies are Reshaping Medicine
DESCRIPTION:Part 1: Wednesday\, May 4\, 2022\, 12:00 – 1:00 PM\nPart 2: Wednesday\, September 14\, 2022\, 12:00 – 1:00 PM \nCellular therapies are reshaping the therapeutic landscape\, representing one of the highest growth sectors for FDA IND applications\, spurring some of the most recognized young companies\, producing several high-value cancer drugs\, and transforming lives. The Seattle area has led the development from the start with seminal work by Dendreon\, bringing to market the first FDA-approved immunotherapy made from a patient’s own immune cells (Provenge)\, as well as pioneering advances in chimeric antigen receptor (CAR) T cell therapy by the Hutch\, Seattle Children’s Research Institute and Juno Therapeutics. Today the region remains at the forefront\, supporting the development and launch of two commercially available CAR T cell products\, Breyanzi (Juno/Celgene/Bristol Myers Squibb) and Abecma (2seventy bio (formerly bluebird bio)/Celgene/Bristol Myers Squibb)\, and delivering innovative cell therapies to put more patients on the path to a cure. Young cellular therapy companies with roots in Seattle such as\, Sana\, 2seventy bio\, Umoja\, GentiBio\, Notch Therapeutics\, Century Therapeutics\, Gilead\, Sonoma Bio\, Lyell\, among others promise to usher in the next era of innovation. The science is established. The patient benefits are real.  The possibilities are endless. \nPart 1 Focus:\n•  Where we are now—FDA Approved Therapies\n•  How we got here—the science in a broad international sense but specifically highlighting Seattle’s history in the development of cellular therapies.\n•  The history of how these therapies have made it to market. Special challenges this new technology had to face such as manufacturing.\n•  What therapies are currently on the market\n•  Special focus on how current therapies are putting more patients on a path to a cure \nPricing: \n$25 in-person (includes lunch and beverages)\n$10 virtual via zoom
URL:https://scienceinseattle.com/event/cellular-therapy-series-part-i-how-engineered-cellular-therapies-are-reshaping-medicine/
LOCATION:Online
ORGANIZER;CN="Life Science Washington":MAILTO:kaitlyn@lifesciencewa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220504T120000
DTEND;TZID=America/Vancouver:20220504T130000
DTSTAMP:20260404T054718
CREATED:20220411T165417Z
LAST-MODIFIED:20220411T165417Z
UID:25875-1651665600-1651669200@scienceinseattle.com
SUMMARY:Cellular Therapy Series Part I: How Engineered Cellular Therapies are Reshaping Medicine
DESCRIPTION:Part 1: Wednesday\, May 4\, 2022\, 12:00 – 1:00 PM\nPart 2: Wednesday\, September 14\, 2022\, 12:00 – 1:00 PM \nCellular therapies are reshaping the therapeutic landscape\, representing one of the highest growth sectors for FDA IND applications\, spurring some of the most recognized young companies\, producing several high-value cancer drugs\, and transforming lives. The Seattle area has led the development from the start with seminal work by Dendreon\, bringing to market the first FDA-approved immunotherapy made from a patient’s own immune cells (Provenge)\, as well as pioneering advances in chimeric antigen receptor (CAR) T cell therapy by the Hutch\, Seattle Children’s Research Institute and Juno Therapeutics. Today the region remains at the forefront\, supporting the development and launch of two commercially available CAR T cell products\, Breyanzi (Juno/Celgene/Bristol Myers Squibb) and Abecma (2seventy bio (formerly bluebird bio)/Celgene/Bristol Myers Squibb)\, and delivering innovative cell therapies to put more patients on the path to a cure. Young cellular therapy companies with roots in Seattle such as\, Sana\, 2seventy bio\, Umoja\, GentiBio\, Notch Therapeutics\, Century Therapeutics\, Gilead\, Sonoma Bio\, Lyell\, among others promise to usher in the next era of innovation. The science is established. The patient benefits are real.  The possibilities are endless. \nPart 1 Focus:\n•  Where we are now—FDA Approved Therapies\n•  How we got here—the science in a broad international sense but specifically highlighting Seattle’s history in the development of cellular therapies.\n•  The history of how these therapies have made it to market. Special challenges this new technology had to face such as manufacturing.\n•  What therapies are currently on the market\n•  Special focus on how current therapies are putting more patients on a path to a cure \nPricing: \n$25 in-person (includes lunch and beverages)\n$10 virtual via zoom
URL:https://scienceinseattle.com/event/cellular-therapy-series-part-i-how-engineered-cellular-therapies-are-reshaping-medicine-2/
LOCATION:Online
ORGANIZER;CN="Life Science Washington":MAILTO:kaitlyn@lifesciencewa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220504T120000
DTEND;TZID=America/Vancouver:20220504T130000
DTSTAMP:20260404T054718
CREATED:20220411T165417Z
LAST-MODIFIED:20220411T165417Z
UID:26840-1651665600-1651669200@scienceinseattle.com
SUMMARY:Cellular Therapy Series Part I: How Engineered Cellular Therapies are Reshaping Medicine
DESCRIPTION:Part 1: Wednesday\, May 4\, 2022\, 12:00 – 1:00 PM\nPart 2: Wednesday\, September 14\, 2022\, 12:00 – 1:00 PM \nCellular therapies are reshaping the therapeutic landscape\, representing one of the highest growth sectors for FDA IND applications\, spurring some of the most recognized young companies\, producing several high-value cancer drugs\, and transforming lives. The Seattle area has led the development from the start with seminal work by Dendreon\, bringing to market the first FDA-approved immunotherapy made from a patient’s own immune cells (Provenge)\, as well as pioneering advances in chimeric antigen receptor (CAR) T cell therapy by the Hutch\, Seattle Children’s Research Institute and Juno Therapeutics. Today the region remains at the forefront\, supporting the development and launch of two commercially available CAR T cell products\, Breyanzi (Juno/Celgene/Bristol Myers Squibb) and Abecma (2seventy bio (formerly bluebird bio)/Celgene/Bristol Myers Squibb)\, and delivering innovative cell therapies to put more patients on the path to a cure. Young cellular therapy companies with roots in Seattle such as\, Sana\, 2seventy bio\, Umoja\, GentiBio\, Notch Therapeutics\, Century Therapeutics\, Gilead\, Sonoma Bio\, Lyell\, among others promise to usher in the next era of innovation. The science is established. The patient benefits are real.  The possibilities are endless. \nPart 1 Focus:\n•  Where we are now—FDA Approved Therapies\n•  How we got here—the science in a broad international sense but specifically highlighting Seattle’s history in the development of cellular therapies.\n•  The history of how these therapies have made it to market. Special challenges this new technology had to face such as manufacturing.\n•  What therapies are currently on the market\n•  Special focus on how current therapies are putting more patients on a path to a cure \nPricing: \n$25 in-person (includes lunch and beverages)\n$10 virtual via zoom
URL:https://scienceinseattle.com/event/cellular-therapy-series-part-i-how-engineered-cellular-therapies-are-reshaping-medicine-3/
LOCATION:Online
ORGANIZER;CN="Life Science Washington":MAILTO:kaitlyn@lifesciencewa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220504T120000
DTEND;TZID=UTC:20220504T130000
DTSTAMP:20260404T054718
CREATED:20220502T180628Z
LAST-MODIFIED:20220502T180628Z
UID:17766-1651665600-1651669200@scienceinseattle.com
SUMMARY:Biostatistics Seminar Series
DESCRIPTION:The Fred Hutch Biostatistics Program hosts seminars featuring presentations by Fred Hutch and outside scientists to share their latest developments and recent research. Each seminar includes an hour-long presentation and discussion during which speakers showcase their work and findings. \nThis seminar will be held on Zoom due to the COVID-19 pandemic. \nPRESENTER: Andy Ni\, Ph.D.\n\n“Contrast Weighted Learning for Robust Optimal Treatment Regimen Estimation”\n\n\nPersonalized medicine aims to tailor medical decisions based on patient-specific characteristics. Advances in data capturing techniques such as electronic health records dramatically increase the availability of comprehensive patient profiles\, promoting the rapid development of optimal treatment rule (OTR) estimation methods. An archetypal OTR estimation approach is the outcome weighted learning\, where OTR is determined under a weighted classification framework with clinical outcomes as the weights. Although outcome weighted learning has been extensively studied and extended\, existing methods are susceptible to irregularities of outcome distributions such as outliers and heavy tails.  Methods that involve modeling of the outcome are also sensitive to model misspecification. We propose a contrast weighted learning (CWL) framework that exploits the flexibility and robustness of contrast functions to enable robust OTR estimation for a wide range of clinical outcomes. The novel value function in CWL only depends on the pairwise contrast of clinical outcomes between patients irrespective of their distributional features and supports. The Fisher consistency and convergence rate of the estimated decision rule via CWL are established. We illustrate the superiority of the proposed method under finite samples using comprehensive simulation studies with ill-distributed continuous outcomes and ordinal outcomes. We apply the CWL method to two datasets from clinical trials on idiopathic pulmonary fibrosis and COVID-19 to demonstrate its real-world application.
URL:https://scienceinseattle.com/event/biostatistics-seminar-series-9/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220504T120000
DTEND;TZID=UTC:20220504T130000
DTSTAMP:20260404T054718
CREATED:20220502T180628Z
LAST-MODIFIED:20220502T180628Z
UID:25889-1651665600-1651669200@scienceinseattle.com
SUMMARY:Biostatistics Seminar Series
DESCRIPTION:The Fred Hutch Biostatistics Program hosts seminars featuring presentations by Fred Hutch and outside scientists to share their latest developments and recent research. Each seminar includes an hour-long presentation and discussion during which speakers showcase their work and findings. \nThis seminar will be held on Zoom due to the COVID-19 pandemic. \nPRESENTER: Andy Ni\, Ph.D.\n\n“Contrast Weighted Learning for Robust Optimal Treatment Regimen Estimation”\n\n\nPersonalized medicine aims to tailor medical decisions based on patient-specific characteristics. Advances in data capturing techniques such as electronic health records dramatically increase the availability of comprehensive patient profiles\, promoting the rapid development of optimal treatment rule (OTR) estimation methods. An archetypal OTR estimation approach is the outcome weighted learning\, where OTR is determined under a weighted classification framework with clinical outcomes as the weights. Although outcome weighted learning has been extensively studied and extended\, existing methods are susceptible to irregularities of outcome distributions such as outliers and heavy tails.  Methods that involve modeling of the outcome are also sensitive to model misspecification. We propose a contrast weighted learning (CWL) framework that exploits the flexibility and robustness of contrast functions to enable robust OTR estimation for a wide range of clinical outcomes. The novel value function in CWL only depends on the pairwise contrast of clinical outcomes between patients irrespective of their distributional features and supports. The Fisher consistency and convergence rate of the estimated decision rule via CWL are established. We illustrate the superiority of the proposed method under finite samples using comprehensive simulation studies with ill-distributed continuous outcomes and ordinal outcomes. We apply the CWL method to two datasets from clinical trials on idiopathic pulmonary fibrosis and COVID-19 to demonstrate its real-world application.
URL:https://scienceinseattle.com/event/biostatistics-seminar-series-9-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220504T120000
DTEND;TZID=UTC:20220504T130000
DTSTAMP:20260404T054718
CREATED:20220502T180628Z
LAST-MODIFIED:20220502T180628Z
UID:26854-1651665600-1651669200@scienceinseattle.com
SUMMARY:Biostatistics Seminar Series
DESCRIPTION:The Fred Hutch Biostatistics Program hosts seminars featuring presentations by Fred Hutch and outside scientists to share their latest developments and recent research. Each seminar includes an hour-long presentation and discussion during which speakers showcase their work and findings. \nThis seminar will be held on Zoom due to the COVID-19 pandemic. \nPRESENTER: Andy Ni\, Ph.D.\n\n“Contrast Weighted Learning for Robust Optimal Treatment Regimen Estimation”\n\n\nPersonalized medicine aims to tailor medical decisions based on patient-specific characteristics. Advances in data capturing techniques such as electronic health records dramatically increase the availability of comprehensive patient profiles\, promoting the rapid development of optimal treatment rule (OTR) estimation methods. An archetypal OTR estimation approach is the outcome weighted learning\, where OTR is determined under a weighted classification framework with clinical outcomes as the weights. Although outcome weighted learning has been extensively studied and extended\, existing methods are susceptible to irregularities of outcome distributions such as outliers and heavy tails.  Methods that involve modeling of the outcome are also sensitive to model misspecification. We propose a contrast weighted learning (CWL) framework that exploits the flexibility and robustness of contrast functions to enable robust OTR estimation for a wide range of clinical outcomes. The novel value function in CWL only depends on the pairwise contrast of clinical outcomes between patients irrespective of their distributional features and supports. The Fisher consistency and convergence rate of the estimated decision rule via CWL are established. We illustrate the superiority of the proposed method under finite samples using comprehensive simulation studies with ill-distributed continuous outcomes and ordinal outcomes. We apply the CWL method to two datasets from clinical trials on idiopathic pulmonary fibrosis and COVID-19 to demonstrate its real-world application.
URL:https://scienceinseattle.com/event/biostatistics-seminar-series-9-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220505
DTEND;VALUE=DATE:20220507
DTSTAMP:20260404T054718
CREATED:20220502T174131Z
LAST-MODIFIED:20220502T174131Z
UID:17725-1651708800-1651881599@scienceinseattle.com
SUMMARY:Art Auction benefiting Seattle Children's Hospital
DESCRIPTION:The Box House is holding an art auction benefiting Seattle Children’s for two days. There will be silent auction items as well as a live auction. Each artist can choose how much of the sale price goes to SCH. The minimum allowed to be donated is is 20%. Art coming in ranges from $50 to $3000 and up.
URL:https://scienceinseattle.com/event/art-auction-benefiting-seattle-childrens-hospital/
LOCATION:Box House/Underground\, 124 South Washington Street\, Seattle\, WA\, 98104\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220505
DTEND;VALUE=DATE:20220507
DTSTAMP:20260404T054718
CREATED:20220502T174131Z
LAST-MODIFIED:20220502T174131Z
UID:25877-1651708800-1651881599@scienceinseattle.com
SUMMARY:Art Auction benefiting Seattle Children's Hospital
DESCRIPTION:The Box House is holding an art auction benefiting Seattle Children’s for two days. There will be silent auction items as well as a live auction. Each artist can choose how much of the sale price goes to SCH. The minimum allowed to be donated is is 20%. Art coming in ranges from $50 to $3000 and up.
URL:https://scienceinseattle.com/event/art-auction-benefiting-seattle-childrens-hospital-2/
LOCATION:Box House/Underground\, 124 South Washington Street\, Seattle\, WA\, 98104\, United States
END:VEVENT
END:VCALENDAR